These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

843 related articles for article (PubMed ID: 33218366)

  • 21. Tricyclic antidepressants versus 'active placebo', placebo or no intervention for adults with major depressive disorder: a protocol for a systematic review with meta-analysis and Trial Sequential Analysis.
    Jørgensen CK; Juul S; Siddiqui F; Barbateskovic M; Munkholm K; Hengartner MP; Kirsch I; Gluud C; Jakobsen JC
    Syst Rev; 2021 Aug; 10(1):227. PubMed ID: 34389045
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Systemic corticosteroids for the treatment of COVID-19.
    Wagner C; Griesel M; Mikolajewska A; Mueller A; Nothacker M; Kley K; Metzendorf MI; Fischer AL; Kopp M; Stegemann M; Skoetz N; Fichtner F
    Cochrane Database Syst Rev; 2021 Aug; 8(8):CD014963. PubMed ID: 34396514
    [TBL] [Abstract][Full Text] [Related]  

  • 23. SARS-CoV-2-neutralising monoclonal antibodies for treatment of COVID-19.
    Kreuzberger N; Hirsch C; Chai KL; Tomlinson E; Khosravi Z; Popp M; Neidhardt M; Piechotta V; Salomon S; Valk SJ; Monsef I; Schmaderer C; Wood EM; So-Osman C; Roberts DJ; McQuilten Z; Estcourt LJ; Skoetz N
    Cochrane Database Syst Rev; 2021 Sep; 9(9):CD013825. PubMed ID: 34473343
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Interventions to support the resilience and mental health of frontline health and social care professionals during and after a disease outbreak, epidemic or pandemic: a mixed methods systematic review.
    Pollock A; Campbell P; Cheyne J; Cowie J; Davis B; McCallum J; McGill K; Elders A; Hagen S; McClurg D; Torrens C; Maxwell M
    Cochrane Database Syst Rev; 2020 Nov; 11(11):CD013779. PubMed ID: 33150970
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The risks of adverse events with venlafaxine and mirtazapine versus 'active placebo', placebo, or no intervention for adults with major depressive disorder: a protocol for two separate systematic reviews with meta-analysis and Trial Sequential Analysis.
    Jørgensen CK; Juul S; Siddiqui F; Horowitz MA; Moncrieff J; Munkholm K; Hengartner MP; Kirsch I; Gluud C; Jakobsen JC
    Syst Rev; 2023 Mar; 12(1):57. PubMed ID: 36991504
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Sexual transmission of SARS-CoV-2 virus and its role in the spread of COVID-19: A living systematic review protocol.
    Duarte G; Ortiz-Muñoz L; Morales MB; Acuña MP; Rada G;
    Medwave; 2020 Nov; 20(10):e8062. PubMed ID: 33361754
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Systemic pharmacological treatments for chronic plaque psoriasis: a network meta-analysis.
    Sbidian E; Chaimani A; Garcia-Doval I; Do G; Hua C; Mazaud C; Droitcourt C; Hughes C; Ingram JR; Naldi L; Chosidow O; Le Cleach L
    Cochrane Database Syst Rev; 2017 Dec; 12(12):CD011535. PubMed ID: 29271481
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Deep brain stimulation for neurological disorders: a protocol for a systematic review with meta-analysis and Trial Sequential Analysis of randomised clinical trials.
    Petersen JJ; Juul S; Jørgensen CK; Gluud C; Jakobsen JC
    Syst Rev; 2022 Oct; 11(1):218. PubMed ID: 36229825
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Safety of COVID-19 vaccines in patients with non-communicable diseases: a protocol for systematic review and meta-analysis of randomised controlled trials.
    Shi C; Wu M; Wang X; Yang K
    BMJ Open; 2022 May; 12(5):e057233. PubMed ID: 35613806
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Corticosteroid therapy for critically ill patients with COVID-19: A structured summary of a study protocol for a prospective meta-analysis of randomized trials.
    Sterne JAC; Diaz J; Villar J; Murthy S; Slutsky AS; Perner A; Jüni P; Angus DC; Annane D; Azevedo LCP; Du B; Dequin PF; Gordon AC; Green C; Higgins JPT; Horby P; Landray MJ; Lapadula G; Le Gouge A; Leclerc M; Savović J; Tomazini B; Venkatesh B; Webb S; Marshall JC;
    Trials; 2020 Aug; 21(1):734. PubMed ID: 32831155
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Side effects of COVID-19 vaccines: a systematic review and meta-analysis protocol of randomised trials.
    Medeiros KS; Costa APF; Sarmento ACA; Freitas CL; Gonçalves AK
    BMJ Open; 2022 Feb; 12(2):e050278. PubMed ID: 35210336
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Mesenchymal stromal cells as a therapeutic intervention for COVID-19: a living systematic review and meta-analysis protocol.
    Kirkham AM; Monaghan M; Bailey AJM; Shorr R; Lalu MM; Fergusson DA; Allan DS
    Syst Rev; 2021 Sep; 10(1):249. PubMed ID: 34526123
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Safety and Efficacy of Imatinib for Hospitalized Adults with COVID-19: A structured summary of a study protocol for a randomised controlled trial.
    Emadi A; Chua JV; Talwani R; Bentzen SM; Baddley J
    Trials; 2020 Oct; 21(1):897. PubMed ID: 33115543
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Double-Blind, Randomized, Placebo-Controlled Phase III Clinical Trial to Evaluate the Efficacy and Safety of treating Healthcare Professionals with the Adsorbed COVID-19 (Inactivated) Vaccine Manufactured by Sinovac - PROFISCOV: A structured summary of a study protocol for a randomised controlled trial.
    Palacios R; Patiño EG; de Oliveira Piorelli R; Conde MTRP; Batista AP; Zeng G; Xin Q; Kallas EG; Flores J; Ockenhouse CF; Gast C
    Trials; 2020 Oct; 21(1):853. PubMed ID: 33059771
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Vaccines for preventing influenza in healthy children.
    Jefferson T; Rivetti A; Di Pietrantonj C; Demicheli V
    Cochrane Database Syst Rev; 2018 Feb; 2(2):CD004879. PubMed ID: 29388195
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Antibiotics for secondary prevention of coronary heart disease.
    Sethi NJ; Safi S; Korang SK; Hróbjartsson A; Skoog M; Gluud C; Jakobsen JC
    Cochrane Database Syst Rev; 2021 Feb; 2(2):CD003610. PubMed ID: 33704780
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A systematic review and meta-analysis protocol examining the clinical characteristics and epidemiological features of olfactory dysfunction (OD) in coronavirus disease 2019 (COVID-19).
    Tan RQ; Li WTV; Shum WZ; Chu SC; Li HL; Shea YF; Chung TW
    Syst Rev; 2021 Mar; 10(1):73. PubMed ID: 33691796
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Comparing the clinical efficacy of COVID-19 vaccines: a systematic review and network meta-analysis.
    Rotshild V; Hirsh-Raccah B; Miskin I; Muszkat M; Matok I
    Sci Rep; 2021 Nov; 11(1):22777. PubMed ID: 34815503
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Adverse effects with semaglutide: a protocol for a systematic review with meta-analysis and trial sequential analysis.
    Sillassen CDB; Kamp CB; Petersen JJ; Faltermeier P; Siddiqui F; Grand J; Dominguez H; Frølich A; Gæde PH; Gluud C; Mathiesen O; Jakobsen J
    BMJ Open; 2024 Jun; 14(6):e084190. PubMed ID: 38908837
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Systemic pharmacological treatments for chronic plaque psoriasis: a network meta-analysis.
    Sbidian E; Chaimani A; Garcia-Doval I; Doney L; Dressler C; Hua C; Hughes C; Naldi L; Afach S; Le Cleach L
    Cochrane Database Syst Rev; 2022 May; 5(5):CD011535. PubMed ID: 35603936
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 43.